

Anti-snoring Treatment Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The anti-snoring treatment market is experiencing significant growth, driven by increasing awareness of sleep disorders and technological advancements. Current market size is estimated at approximately $1.2 billion, with a projected CAGR of 8% over the next five years, highlighting a rising demand for innovative solutions and personalized treatment options.
◍ Foundation Care (Theravent)
◍ Tomed Dr. Toussaint Gmbh
◍ Philips Healthcare
◍ The Pure Sleep Company
◍ Apnea Sciences Corporation
◍ SomnoMed
◍ Meditas
◍ Airway Management Inc.
◍ GlaxoSmithKline plc
◍ Fisher & Paykel Healthcare
◍ Resmed
◍ Medtronic
The anti-snoring treatment market features companies like Philips Healthcare and Resmed innovating with devices and therapies to reduce snoring. Foundation Care focuses on consumer products, while Apnea Sciences and SomnoMed develop advanced oral appliances. These firms enhance product availability and awareness, contributing to market growth through diverse offerings. Sales figures include:
- Philips Healthcare: ~$18 billion (2022)
- Resmed: ~$3.3 billion (2022)
- Medtronic: ~$30 billion (2022)
- GlaxoSmithKline: ~$45 billion (2022).
Request Sample Report
Hospitals
Clinics
Retail Pharmacies
E-Commerce
Request Sample Report
Device
Surgery
Others
Request Sample Report
$ X Billion USD